Breaking News Instant updates and real-time market news.

AKRX

Akorn

$3.93

-0.01 (-0.25%)

08:25
01/09/19
01/09
08:25
01/09/19
08:25

Akorn trading resumes

AKRX Akorn
$3.93

-0.01 (-0.25%)

11/26/18
RBCM
11/26/18
NO CHANGE
RBCM
Sector Perform
Akorn gets FDA approval for generic Voltaren Gel, says RBC Capital
RBC Capital analyst Randall Stanicky said his "back and forth with management" at Akorn confirmed that the company received FDA approval for its generic version of Voltaren Gel, which the analyst notes represents the third ANDA approval from the company's Amityville facility since October. Stanicky, who continues to watch the company's ongoing litigation as well as its progress on the remediation of its Decatur and Somerset facilities, keeps a Sector Perform rating on Akorn shares.
11/27/18
PIPR
11/27/18
NO CHANGE
Target $9
PIPR
Overweight
Akorn approval an 'encouraging development,' says Piper Jaffray
Piper Jaffray analyst David Amsellem views Akorn's (AKRX) approval of its generic of Voltaren Gel as an "encouraging development." The news demonstrates that the company can execute on the approval of products on the more technically challenging end of the generics spectrum, Amsellem tells investors in a research note. The analyst believes Akorn is well positioned for "significant EBITDA recovery" over the next two years. He sees a "high likelihood" that the company in 2018 will have worked through the bulk of the erosion of key generics due to competition and a "relatively high" probability of meaningful cost reductions if it loses its appeal in its case against Fresenius (FSNUY). Amsellem reiterates an Overweight rating on Akorn with a $9 price target.
12/07/18
CHLM
12/07/18
NO CHANGE
Target $11
CHLM
Buy
Craig-Hallum maintains Buy rating, $11 target on Akorn after Fresenius ruling
Craig-Hallum analyst Matt Hewitt said the Delaware Supreme Court ruling in favor of Fresenius (FSNUY) ends any hopes that a merger with Akorn (AKRX) will still occur, which may be a disappointment to some investors. However, it has been his view since the first ruling was announced that Akorn should be valued on a standalone basis. Akorn currently has a large pipeline of higher margin generics and the company's low-cost manufacturing facility in India has been idled due to the terms of the Fresenius agreement, but is likely to be brought online sometime in FY19 or FY20, Hewitt tells investors. He keeps a Buy rating and $11 price target on Akorn shares, which are down $1.34, or 24%, to $4.25 in afternoon trading.
12/10/18
PIPR
12/10/18
NO CHANGE
Target $9
PIPR
Overweight
Piper does not view Akorn as 'major fixer-upper,' keeps $9 target
Piper Jaffray analyst David Amsellem says he would not view Akorn (AKRX) as a "major fixer-upper" now that it is planning to move forward as a stand-alone company. Much of the pressure on EBITDA in recent years was a function of limited-competition products with brand-like margins, Amsellem tells investors in a research note. Further, the rest of Akorn's product portfolio appears to be stable, says the analyst. In addition, "high-quality" abbreviated new drug application approvals have been happening, "and that matters," argues Amsellem. He keeps an Overweight rating on Akorn with a $9 price target.

TODAY'S FREE FLY STORIES

MBIO

Mustang Bio

$4.15

(0.00%)

, FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

10:05
02/20/19
02/20
10:05
02/20/19
10:05
Recommendations
Mustang Bio, Fortress Biotech analyst commentary  »

Mustang Bio partnership…

MBIO

Mustang Bio

$4.15

(0.00%)

FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$39.47

0.1 (0.25%)

, DGII

Digi International

$13.40

0.04 (0.30%)

10:03
02/20/19
02/20
10:03
02/20/19
10:03
Hot Stocks
Trimble, Digi collaborate to provide fleets with cold chain compliance solution »

Trimble (TRMB) announced…

TRMB

Trimble

$39.47

0.1 (0.25%)

DGII

Digi International

$13.40

0.04 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 05

    Mar

  • 14

    Mar

WWW

Wolverine World Wide

$35.90

-3.6 (-9.11%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Wolverine World Wide falls -9.1% »

Wolverine World Wide is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

LC

LendingClub

$3.27

-0.355 (-9.81%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
LendingClub falls -10.4% »

LendingClub is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.46

-1.48 (-18.64%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Owens & Minor falls -18.5% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NVTA

Invitae

$18.07

1.58 (9.58%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Invitae rises 9.0% »

Invitae is up 9.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$62.43

5.79 (10.22%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Belden rises 9.8% »

Belden is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 13

    May

  • 14

    May

  • 15

    May

F

Ford

$8.94

0.11 (1.25%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Options
Put buyers in Ford shortly after the opening bell Wednesday »

Put buyers in Ford…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

DVN

Devon Energy

$32.15

3.84 (13.56%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Devon Energy rises 13.6% »

Devon Energy is up 13.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

TSLA

Tesla

$304.81

-0.75 (-0.25%)

09:58
02/20/19
02/20
09:58
02/20/19
09:58
On The Fly
Tesla drops as general counsel leaves after just two months »

Shares of Tesla (TSLA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

ET

Energy Transfer LP

$15.64

(0.00%)

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Options
Energy Transfer put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GRMN

Garmin

$79.73

8.77 (12.36%)

, DVN

Devon Energy

$31.90

3.59 (12.68%)

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Options
Early notable gainers among liquid option names on February 20th »

Notable gainers among…

GRMN

Garmin

$79.73

8.77 (12.36%)

DVN

Devon Energy

$31.90

3.59 (12.68%)

CF

CF Industries

$43.09

1.07 (2.55%)

HST

Host Hotels

$18.93

0.41 (2.21%)

PCG

PG&E

$18.03

0.28 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

  • 28

    May

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

FB

Facebook

$163.50

1.21 (0.75%)

, GOOG

Alphabet

$1,120.70

2.54 (0.23%)

09:54
02/20/19
02/20
09:54
02/20/19
09:54
Periodicals
EU countries back copyright reforms targeting Facebook, Google, Reuters says »

A majority of EU…

FB

Facebook

$163.50

1.21 (0.75%)

GOOG

Alphabet

$1,120.70

2.54 (0.23%)

GOOGL

Alphabet Class A

$1,128.63

2.2 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

NAV

Navistar

$36.77

0.24 (0.66%)

, PCAR

Paccar

$68.19

-0.02 (-0.03%)

09:51
02/20/19
02/20
09:51
02/20/19
09:51
Recommendations
Navistar, Paccar, Volkswagen analyst commentary  »

Navistar checks…

NAV

Navistar

$36.77

0.24 (0.66%)

PCAR

Paccar

$68.19

-0.02 (-0.03%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$36.00

-4.41 (-10.91%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
Aerojet Rocketdyne falls -9.8% »

Aerojet Rocketdyne is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LC

LendingClub

$3.22

-0.4 (-11.05%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
LendingClub falls -11.1% »

LendingClub is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.38

-1.56 (-19.65%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
Owens & Minor falls -19.8% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

LZB

La-Z-Boy

$34.53

2.305 (7.15%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
La-Z-Boy rises 7.1% »

La-Z-Boy is up 7.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NVTA

Invitae

$17.77

1.28 (7.76%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
Invitae rises 9.3% »

Invitae is up 9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

DVN

Devon Energy

$31.20

2.89 (10.21%)

09:47
02/20/19
02/20
09:47
02/20/19
09:47
Hot Stocks
Devon Energy rises 10.3% »

Devon Energy is up 10.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

09:46
02/20/19
02/20
09:46
02/20/19
09:46
General news
Market little changed as Fed minutes loom »

Stock futures drifted…

09:45
02/20/19
02/20
09:45
02/20/19
09:45
General news
Treasury Action: positioning data showed a rise in neutrals »

Treasury Action:…

CCI

Crown Castle

$120.17

(0.00%)

, NEE

NextEra Energy

$185.39

(0.00%)

09:40
02/20/19
02/20
09:40
02/20/19
09:40
Options
Unusually active option classes on open February 20th »

Unusual total active…

CCI

Crown Castle

$120.17

(0.00%)

NEE

NextEra Energy

$185.39

(0.00%)

DVN

Devon Energy

$28.31

(0.00%)

CVS

CVS Health

$69.92

(0.00%)

ELAN

Elanco

$29.18

(0.00%)

FCX

Freeport McMoRan

$13.09

(0.00%)

BHC

Bausch Health

$25.17

(0.00%)

WMT

Walmart

$102.23

(0.00%)

ADBE

Adobe

$257.84

(0.00%)

F

Ford

$8.83

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 24

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

  • 14

    Mar

  • 25

    Apr

  • 22

    May

  • 24

    Jul

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.